Hostname: page-component-76fb5796d-r6qrq Total loading time: 0 Render date: 2024-04-25T13:29:28.966Z Has data issue: false hasContentIssue false
  • English
  • Français

Opioid antagonist peptides derived from κ-casein

Published online by Cambridge University Press:  01 June 2009

Hideo Chiba ,
Fumito Tani  and
Masaaki Yoshikawa
Hideo Chiba
Affiliation:
Department of Food Science and Technology, Faculty of Agriculture, Kyoto Univeristy, Kyoto 606, Japan
Fumito Tani
Affiliation:
Department of Food Science and Technology, Faculty of Agriculture, Kyoto Univeristy, Kyoto 606, Japan
Masaaki Yoshikawa
Affiliation:
Department of Food Science and Technology, Faculty of Agriculture, Kyoto Univeristy, Kyoto 606, Japan
Get access Rights & Permissions [Opens in a new window]

Summary

Opioid antagonists were sought in the fragments of κ-casein which were obtained by chemical synthesis and enzymic digestion. A synthetic bovine κ-casein peptide (35–41), Tyr-Pro-Ser-Tyr-Gly-Leu-Asn (casoxin A) showed opioid antagonist activity at 200 μM in the guinea pig ileum assay. A synthetic peptide Tyr-Pro-Tyr-Tyr (casoxin B) which is found in bovine and human κ-casein, also showed opioid antagonist activity at 100 μM. Another opioid antagonist peptide (casoxin C) was isolated from tryptic digests of bovine κ-casein by reverse-phase HPLC. The structure of the peptide was Tyr-Ile-Pro-Ile-Gln-Tyr-Val-Leu-Ser-Arg, which corresponded to κ-casein (25–34). Casoxin C was active at 5 μM in the guinea pig ileum assay. Thus, bovine κ-casein contains three potential opioid antagonist sequences.

Type
Original Articles
Information
Journal of Dairy Research , Volume 56 , Issue 3: Special Issue: Proceedings of the Hannah Research Institute Casein Conference , May 1989 , pp. 363 - 366
Copyright
Copyright © Proprietors of Journal of Dairy Research 1989

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

Berthou, J., Migliore-Samour, D., Lifchitz, A., Delettré, J., Floc'H., F. & Jollés, P. 1987 Immunostimulating properties and three-dimensional structure of two tripeptides from human and cow caseins. FEBS Letters 218 55–58CrossRefGoogle ScholarPubMed
Brantl, V., Teschemacher, H., Henschen, A. & Lottspeich, F. 1979 Novel opioid peptides derived from casein (β-casomorphins), I. Isolation from bovine casein peptone. Hoppe-Seyler's Zeitschrift für Physiologische Chemie 360 1211–1216CrossRefGoogle ScholarPubMed
Brignon, G., Chtourou, A. & Ribadeau-Dumas, B. 1985 Preparation and amino acid sequence of human κ-casein. FEBS Letters 188 48–54CrossRefGoogle ScholarPubMed
Chiba, H. & Yoshikawa, M. 1986 Biologically functional peptides from food proteins: New opioid peptides from milk proteins. In Protein Tailoring for Food and Medical Uses pp. 123–153 (eds Feeney, R. E. and Whitaker, J. R.). New York: Marcel DekkerGoogle Scholar
Henschen, A., Lottspeich, F., Brantl, V. & Teschemacher, H. 1979 Novel Opioid peptide derived from casein β-casomorphins). II. Structure of active components from bovine casein peptone. Hoppe-Seyler's Zeitschrift für Physiologische Chemie 360 1217–1224.Google ScholarPubMed
Loukas, S., Varoucha, D., Zioudrou, G., Streaty, R. A. & Klee, W. A. 1983 Opioid activities and structures of α-casein-derived exorphins. Biochemistry 22 4567–4573CrossRefGoogle ScholarPubMed
Maruyama, S., Nakagomi, K., Tomizuka, N. & Suzuki, H. 1985 Angiotensin I converting enzyme inhibitor derived from an enzymatic hydrolysate of casein. II. Isolation and bradykinin-potentiating activity on the uterus and the ileum of rats. Agricultural and Biological Chemistry 49 1405–1409Google Scholar
Maruyama, S. & Suzuki, H. 1982 A peptide inhibitor of angiotensin I converting enzyme inhibitor in the tryptic hydrolysate of casein. Agricultural and Biological Chemistry 46 1393–1394Google Scholar
Mercier, J.-C., Brignon, G. & Ribadeau-Dumas, B. 1973 Structure primaire de la caséine κB bovine, Sequence complete. European Journal of Biochemistry 35 222–235CrossRefGoogle Scholar
Parker, F., Migliore-Samour, D., Floc'H, F., Zerial, A., Werner, G. H., Jollès, J., Casaretto, M., Zahn, H. & Jollès, P. 1984 Immunostimulating hexapeptide from human casein: amino acid sequence, synthesis and biological properties. European Journal of Biochemistry 145 677–682CrossRefGoogle ScholarPubMed
Yoshikawa, M., Tani, F., Ashikaga, T., Yoshimara, T. & Chiba, H. 1986 b Purification and characterization of an opioid antagonist from peptic: digest of bovine κcasein. Agricultural and Biological Chemistry 50 2951–2954Google Scholar
Yoshikawa, M., Tani, F. & Chiba, H. 1988 Structure-activity relationship of opioid antagonist peptides derived from milk proteins. In Peptide Chemistry 1987 pp. 473–476 (Ed. Shiba, T.). Osaka: Protein Research FoundationGoogle Scholar
Yoshikawa, M., Tani, F., Yoshimura, T. & Chiba, H. 1986 a Opioid peptides from milk proteins. Agricultural and Biological Chemistry 50 2419–2421CrossRefGoogle Scholar
Yoshikawa, M., Yoshimura, T. & Chiba, H. 1984 Opioid peptides from human β-casein. Agricultural and Biological Chemistry 48 3185–3187CrossRefGoogle Scholar
Zioudrou, C., Streaty, R. A. & Klee, W. A. 1979 Opioid peptides derived from food proteins, the exorphins. Journal of Biological Chemistry 254 2446–2449CrossRefGoogle ScholarPubMed